DIN 02552523 — DAYBUE 200 MG
DAYBUE is a solution of Trofinetide marketed by ACADIA PHARMACEUTICALS INC.. The full Trofinetide monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02552523
- Brand name
- DAYBUE
- Active ingredient
- Trofinetide
- Strength
- 200 MG
- Dosage form
- SOLUTION
- Route
- GASTRIC; ORAL
- Manufacturer
- ACADIA PHARMACEUTICALS INC.
- Health Canada status
- MARKETED
- Drug class
- Synthetic IGF-1 tripeptide analog (Rett syndrome therapy)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.